NCT03686124 2026-04-13
ACTengine
Immatics US, Inc.
Phase 1/2 Recruiting
Immatics US, Inc.
H. Lee Moffitt Cancer Center and Research Institute
IDEAYA Biosciences
Linnaeus Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Thomas Jefferson University
Novelwise Pharmaceutical Corporation
St Vincent's Hospital, Sydney
Erasmus Medical Center